A predictive survival model for patients with head and neck squamous cell carcinoma treated with immune check point inhibitors.
Bonomi M, Bhateja P, Issa M, Klamer B, Pan X, Blakaj A, Karivedu V, Mousa L, Mitchell D, Gamez M, Kang S, Seim NB, Old M, Carrau R, Rocco J, Blakaj D.
Bonomi M, et al. Among authors: pan x.
Oral Oncol. 2020 Nov;110:104900. doi: 10.1016/j.oraloncology.2020.104900. Epub 2020 Jul 20.
Oral Oncol. 2020.
PMID: 32702630
Free article.